These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23197004)

  • 1. Image cytometric HER2 in gastric carcinoma: is a new algorithm needed?
    Ormenisan C; Wang J; Lawson D; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):414-9. PubMed ID: 23197004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies.
    Robertson SA; Cimino-Mathews A; Cornish TC
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):35-39. PubMed ID: 27153447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases.
    Liu X; Wang X; Wang B; Ren G; Ding W
    Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):459-64. PubMed ID: 26317310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
    Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
    Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible?
    Wong DD; de Boer WB; Platten MA; Jo VY; Cibas ES; Kumarasinghe MP
    Diagn Cytopathol; 2015 Jan; 43(1):80-5. PubMed ID: 25363414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
    Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C
    J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience.
    Varga Z; Noske A
    PLoS One; 2015; 10(10):e0140652. PubMed ID: 26473483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Well-differentiated invasive breast cancers with equivocal HER2 immunohistochemistry: what is the yield of routine reflex in-situ hybridization testing?
    Bethune GC; Pettit AS; Veldhuijzen van Zanten D; Barnes PJ
    Histopathology; 2017 May; 70(6):966-974. PubMed ID: 28032917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma.
    Nergiz D; Alikanoğlu AS; Süren D; Gömceli İ; Öztürk B
    Indian J Pathol Microbiol; 2022; 65(2):321-327. PubMed ID: 35435366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: emerging questions and considerations addressed.
    D'Alfonso T; Liu YF; Monni S; Rosen PP; Shin SJ
    Am J Surg Pathol; 2010 Apr; 34(4):575-81. PubMed ID: 20216378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria.
    Schalper KA; Kumar S; Hui P; Rimm DL; Gershkovich P
    Arch Pathol Lab Med; 2014 Feb; 138(2):213-9. PubMed ID: 24164555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
    Wang T; Hsieh ET; Henry P; Hanna W; Streutker CJ; Grin A
    Hum Pathol; 2014 May; 45(5):970-5. PubMed ID: 24656529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of automated Her2 evaluation in breast cancer: a study on 272 equivocal (score 2+) Her2 immunoreactive cases using an FDA approved system.
    Cantaloni C; Tonini R E; Eccher C; Morelli L; Leonardi E; Bragantini E; Aldovini D; Fasanella S; Ferro A; Cazzolli D; Berlanda G; Dalla Palma P; Barbareschi M
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):306-12. PubMed ID: 21293256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
    Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
    Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of HER2 by automated FISH and IHC in gastric carcinoma biopsies.
    Silva MR; Alarcão A; Ferreira T; d'Aguiar M; Ladeirinha A; Balseiro S; Carvalho L
    Int J Biol Markers; 2016 Feb; 31(1):e38-43. PubMed ID: 26349667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Specimen Type and Specimen Number on HER2 Status in Gastroesophageal Junction and Gastric Adenocarcinoma.
    Huber AR; Buscaglia B; Koltz BR; Henry J; McMahon L; Guo J; Hicks DG; Whitney-Miller CL
    Am J Clin Pathol; 2019 Apr; 151(5):461-468. PubMed ID: 30624589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoplex LightCycler polymerase chain reaction quantitation of the HER2 gene for quality assurance of HER2/neu testing by immunohistochemistry and fluorescence in situ hybridization.
    Layfield LJ; Willmore-Payne C; Isom G; Holden JA
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):562-7. PubMed ID: 18948825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
    Lim SJ; Cantillep A; Carpenter PM
    Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases.
    Liu ZH; Wang K; Lin DY; Xu J; Chen J; Long XY; Ge Y; Luo XL; Zhang KP; Liu YH; Xu FP
    Breast Cancer Res Treat; 2019 May; 175(1):51-57. PubMed ID: 30712197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.